Optomed Q1: A solid start to the year - Redeye

Redeye provides an update following Optomed’s Q1 2025 report. The quarterly sales beat our expectations, and we are positive about seeing Aurora AEYE’s impact during the quarter. We only make minor estimate changes based on the report, but argue that the quarterly figures create confidence in our projections.

Länk till analysen i sin helhet: https://www.redeye.se/research/1103662/optomed-q1-a-solid-start-to-the-year?utm_source=finwire&utm_medium=RSS